Research Article
CPH-I and HE4 Are More Favorable Than CA125 in Differentiating Borderline Ovarian Tumors from Epithelial Ovarian Cancer at Early Stages
Figure 2
ROC curve analyses of the diagnostic values of CA125 and HE4 levels and ROMA and CPH-I indices for BOT I+II and EOC I+II in serous (a), mucinous (b), and endometrioid (c) tumors. Abbreviations: = AUC-ROC; a, b, and c = value of AUC-ROC compared with CA125, HE4, and ROMA, respectively.
(a) |
(b) |
(c) |